Publication:
In reply to Mehanna h et al.

dc.contributor.coauthorSomay, Efsun
dc.contributor.coauthorTopkan, Erkan
dc.contributor.coauthorPehlivan, Berrin
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSelek, Uğur
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:36:58Z
dc.date.issued2023
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue5
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume48
dc.identifier.doi10.1111/coa.14079
dc.identifier.eissn1749-4486
dc.identifier.issn1749-4478
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85162145998
dc.identifier.urihttps://doi.org/10.1111/coa.14079
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22207
dc.identifier.wos1014998400001
dc.keywordsHead
dc.keywordsAntineoplastic agent
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofClinical Otolaryngology
dc.subjectOtorhinolaryngology
dc.titleIn reply to Mehanna h et al.
dc.title.alternativeUntitled Reply
dc.typeLetter
dspace.entity.typePublication
local.contributor.kuauthorSelek, Uğur
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files